Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd.

CourtDistrict Court, S.D. California
DecidedFebruary 9, 2021
Docket3:20-cv-01723
StatusUnknown

This text of Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd. (Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd., (S.D. Cal. 2021).

Opinion

1 2 3 4 5 6 7 8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 DR. MORTEZA NAGHAVI, M.D., an Case No.: 20-cv-01723-H-KSC individual; MEDITEX CAPITAL, LLC, a 12 Delaware limited liability company; and ORDER: 13 AMERICAN HEART TECHNOLOGIES, LLC, a Delaware limited liability (1) GRANTING DEFENDANT 14 company, EASTONE’S MOTION TO DISMISS 15 FOR LACK OF PERSONAL Plaintiffs, JURSIDICTION; AND 16 v. 17 (2) DENYING DEFENDANT BELTER HEALTH MEASUREMENT BELTER’S MOTION TO DISMISS 18 AND ANALYSIS TECHNOLOGY CO., FOR FAILURE TO STATE A CLAIM LTD., a China corporation; EASTONE 19 CENTURY TECHNOLOGY CO. LTD., a [Doc. Nos. 17, 18.] 20 China corporation; XIBIN XU, an individual; WEI WANG, an individual; 21 WENWEI TONG, an individual; 22 FEIPENG ZHONG, an individual; ZHUHAI HENGQIN XUANYUAN NO. 23 8 EQUITY INVESTMENT 24 PARTNERSHIP (LIMITED PARTNERSHIP), a China limited 25 partnership; GF SECURITIES, a China 26 corporation; and DOES 1 through 20, inclusive, 27 Defendants. 28 1 On December 3, 2020, Defendant Eastone Century Technology Co., Ltd. filed a 2 motion to dismiss Plaintiffs Dr. Morteza Naghavi, M.D., Meditex Capital, LLC, and 3 American Heart Technologies, LLC’s second amended complaint pursuant to Federal Rule 4 of Civil Procedure 12(b)(2) for lack of personal jurisdiction and pursuant to Rule 12(b)(6) 5 for failure to state a claim. (Doc. No. 17.) On December 3, 2020, Defendant Belter Health 6 Measurement and Analysis Technology Co., Ltd. filed notice of joinder in the Rule 7 12(b)(6) portion of Defendant Eastone’s motion to dismiss. (Doc. No. 18.) On December 8 14, 2020, the Court took the matter under submission. (Doc. No. 19.) On December 28, 9 2020, Plaintiffs filed a response in opposition to the motion to dismiss. (Doc. No. 20.) On 10 January 4, 2021, Defendants filed their replies. (Doc. No. 21, 22.) For the reasons below, 11 the Court grants Defendant Eastone’s motion to dismiss for lack of personal jurisdiction, 12 and the Court denies Defendant Belter’s motion to dismiss for failure to state a claim. 13 BACKGROUND 14 The following facts are taken from the allegations in Plaintiffs’ second amended 15 complaint. Plaintiffs Meditex Capital, LLC and American Heart Technologies, LLC are 16 Delaware limited liability companies and are partners in a joint venture to manufacture, 17 market, and distribute cardiovascular devices, including a cardiovascular device called 18 “VENDYS.” (Doc. No. 16, SAC ¶¶ 1-2, 17.) Plaintiff Dr. Morteza Naghavi is the founder 19 and managing member of Meditex and American Heart. (Id. ¶¶ 3, 17.) 20 Defendant Belter Health Measurement and Analysis Technology Co., Ltd. is a 21 manufacturer and distributor of medical devices in China. (Id. ¶¶ 4, 18-20.) Defendant 22 Eastone Century Technology Co., Ltd. is a publicly traded China corporation and was the 23 100% owner of Belter until on or about January 2020.1 (Id. ¶ 5.) 24 On March 18, 2016, Belter and Meditex entered into a “Manufacturing, Marketing, 25 Sales and Distribution Agreement” (“the March 18, 2016 agreement”) wherein Meditex 26 27 28 1 On or about January 2020, Eastone sold its ownership interest in Belter to Zhuhai Hengqin 1 granted Belter exclusive rights to market, distribute, and sell VENDYS in China. (Doc. 2 No. 16, SAC ¶ 21, Ex. B at 1, 2 § 2.4.) On February 10, 2017, Belter and Meditex entered 3 into an amendment to the March 18, 2016 agreement (“the February 10, 2017 agreement”). 4 (Id. ¶ 23, Ex. D.) 5 On May 2, 2017, Belter and Meditex entered into another agreement entitled the 6 “Exclusive China Marketing, Sales, and Distribution Agreement” (“the May 2, 2017 7 agreement”). (Id. ¶ 24; Doc. No. 14 Ex. F.) The May 2, 2017 agreement provides: “This 8 contract substitutes all terms related to MARKETING, SALES, and DISTRIBUTION 9 AGREEMENT previously signed by the parties on March 18th, 2016.” (Id., Ex. F at 1.) 10 Plaintiffs allege that the May 2, 2017 agreement contains certain minimum sales 11 requirements, and that Defendant Belter has failed to meet those minimum sales 12 requirements. (Id. ¶¶ 24, 35; see id., Ex. F at 3 § 5, Ex. B.) 13 On August 10, 2018, Belter and Meditex entered into an additional amendment 14 agreement (“the August 10, 2018 amendment”). (Doc. No. 16, SAC ¶ 31, Ex. J.) Plaintiffs 15 allege that under the terms of the August 10, 2018 amendment, Belter was required to pay 16 Meditex $250,000 for an outstanding licensing fee, and Belter was required to provide 17 additional VENDYS units to Plaintiffs in the United States. (Id. ¶ 31.) Plaintiffs allege 18 that although Defendants Belter and Eastone have paid $100,000 of the outstanding 19 $250,000, they have failed to pay the remaining $150,000 of the licensing fee and have not 20 delivered the required VENDYS units. (Id. ¶ 32.) 21 On November 26, 2019, Plaintiffs Dr. Naghavi, Meditex, and American Heart 22 Technologies filed a complaint in the Superior Court of California, County of San Diego. 23 (Doc. No. 1, Notice of Removal ¶ 1.) On February 7, 2020, Plaintiffs filed a first amended 24 complaint in state court against Defendants Belter, Eastone, Xibin Xu, Wei Wang, Wenwei 25 Tong, Feipeng Zhong, Zhuhai Hengqin Xuanyuan, and GF Securities. (Doc. No. 1-13, 26 FAC.) In the FAC, Plaintiffs alleged claims for: (1) breach of contract; (2) breach of the 27 implied covenant of good faith and fair dealing; (3) fraud by false promise; (4) to set aside 28 a voidable transaction; and (5) conspiracy. (Id. ¶¶ 34-72.) 1 On September 2, 2020, Defendants Belter and Eastone removed the action from state 2 court to the United States District Court for the Southern District of California pursuant to 3 28 U.S.C. § 1441 on the basis of diversity jurisdiction under 28 U.S.C. § 1332. (Doc. No. 4 1, Notice of Removal.) On October 6, 2020, the Court granted Defendant GF Securities’s 5 motion to dismiss, and the Court dismissed Defendant GF Securities from the action. (Doc. 6 No. 10.) On October 20, 2020, the Court granted in part and denied in part Defendant 7 Belter’s motion to dismiss, and the Court granted Defendant Eastone’s motion to dismiss. 8 (Doc. No. 15.) Specifically, the Court dismissed Plaintiffs’ claims for breach of the implied 9 covenant of good faith and fair dealing; to set aside a voidable transaction; and conspiracy 10 without leave to amend; the Court dismissed Plaintiff’s claim for breach of contract against 11 Defendant Eastone without leave to amend; and the Court dismissed Plaintiff’s claim for 12 fraud with leave to amend. (Id. at 15.) 13 On November 19, 2020, Plaintiffs filed a second amended complaint against 14 Defendants Belter, Eastone, Xu, Wang, Tong, and Zhong, alleging: (1) a claim for breach 15 of contract against Belter; and (2) a claim for fraud against all the Defendants.2 (Doc. No. 16 16.) By the present motion: (1) Defendant Eastone moves to dismiss Plaintiffs’ fraud claim 17 pursuant to Federal Rule of Civil Procedure 12(b)(2) for lack of personal jurisdiction; and 18 Defendants Eastone and Belter move pursuant to Federal Rule of Civil Procedure 12(b)(6) 19 to dismiss Plaintiff’s fraud claim for failure to state a claim. (Doc. Nos. 17-1, 18.) 20 /// 21

22 2 The Court notes that the second amended complaint appears to re-allege Plaintiffs’ claim for 23 breach of contract against Defendant Eastone. (See Doc. No. 16, SAC ¶¶ 33-43.) This would appear to 24 be an error as Plaintiffs previously agreed to dismiss Defendant Eastone from their breach of contract claim, (see Doc. No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Calder v. Jones
465 U.S. 783 (Supreme Court, 1984)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
United States v. Bestfoods
524 U.S. 51 (Supreme Court, 1998)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
TELESAURUS VPC, LLC v. Power
623 F.3d 998 (Ninth Circuit, 2010)
Gary S. v. Manchester School District
374 F.3d 15 (First Circuit, 2004)
Conservation Force v. Salazar
646 F.3d 1240 (Ninth Circuit, 2011)
Mavrix Photo, Inc. v. Brand Technologies, Inc.
647 F.3d 1218 (Ninth Circuit, 2011)
Vess v. Ciba-Geigy Corp. USA
317 F.3d 1097 (Ninth Circuit, 2003)
Dow Chemical Co. v. Calderon
422 F.3d 827 (Ninth Circuit, 2005)
Zamani v. Carnes
491 F.3d 990 (Ninth Circuit, 2007)
Mendiondo v. Centinela Hospital Medical Center
521 F.3d 1097 (Ninth Circuit, 2008)
Coto Settlement v. Eisenberg
593 F.3d 1031 (Ninth Circuit, 2010)
Hale v. United States Postal Service
663 F. Supp. 7 (N.D. Illinois, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
Naghavi v. Belter Health Measurement and Analysis Technology Co., Ltd., Counsel Stack Legal Research, https://law.counselstack.com/opinion/naghavi-v-belter-health-measurement-and-analysis-technology-co-ltd-casd-2021.